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Abstract
RNase T1 is the best known representative of a large family of ribonucleolytic
proteins secreted by fungi, mostly Aspergillus and Penicillium species. Ribotoxins
stand out among them by their cytotoxic character. They exert their toxic action by
first entering the cells and then cleaving a single phosphodiester bond located
within a universally conserved sequence of the large rRNA gene, known as the
sarcin–ricin loop. This cleavage leads to inhibition of protein biosynthesis,
followed by cellular death by apoptosis. Although no protein receptor has been
found for ribotoxins, they preferentially kill cells showing altered membrane
permeability, such as those that are infected with virus or transformed. Many steps
of the cytotoxic process have been elucidated at the molecular level by means of a
variety of methodological approaches and the construction and purification of
different mutant versions of these ribotoxins. Ribotoxins have been used for the
construction of immunotoxins, because of their cytotoxicity. Besides this activity,
Aspf1, a ribotoxin produced by Aspergillus fumigatus, has been shown to be one of
the major allergens involved in allergic aspergillosis-related pathologies. Protein
engineering and peptide synthesis have been used in order to understand the basis
of these pathogenic mechanisms as well as to produce hypoallergenic proteins with
potential diagnostic and immunotherapeutic applications.
Introduction
Ribotoxins are a family of toxic extracellular fungal RNases
that exert ribonucleolytic activity on the larger molecule of
RNA in the ribosome, leading to protein synthesis inhibition
and cell death by apoptosis (Gasset et al., 1994; Kao et al.,
2001; Martı´nez-Ruiz et al., 2001). Several studies have
suggested that their location on the surface of fungal
conidiophores correlates with the maturation of the conidia
(Brandhorst & Kenealy, 1992; Yang & Kenealy, 1992a, b).
Ribotoxins were discovered during a screening program of
the Michigan Department of Health, started in 1956,
searching for antibiotics and antitumor agents. The culture
filtrates of a mold isolated from a sample of Michigan farm
soil were found to contain a substance inhibitory to both
sarcoma 180 and carcinoma 755 induced in mice (Olson
et al., 1965b). The mold was identified as Aspergillus
giganteus MDH18894 (Fig. 1a), and the molecule responsi-
ble for these effects proved to be a protein, named a-sarcin
(Fig. 1b) (Olson & Goerner, 1965). Two other antitumor
proteins, restrictocin and mitogillin, both produced by A.
restrictus, were later found to have similar activities, and
were therefore included within the same group of antitumor
molecules. Aspf1, another ribotoxin, produced by Aspergil-
lus fumigatus, was much later identified as a major allergen
in Aspergillus-related diseases (Arruda et al., 1992). Unfor-
tunately, further studies revealed an unspecific cytotoxicity
of these proteins, which limited their potential clinical
uses (Roga et al., 1971). The study of these toxins was
abandoned until the mid-1970s, when it was demonstrated
that they inhibited protein biosynthesis in ribosomal pre-
parations at concentrations as low as 0.1 nM by specifically
cleaving a single phosphodiester bond of the large rRNA
gene fragment (Schindler & Davies, 1977; Endo & Wool,
1982). This bond is of particular interest, because it is
located at an evolutionarily conserved site with important
roles in ribosome function, elongation factor 1 (EF-1)-
dependent binding of aminoacyl-tRNA, and EF-2-catalyzed
GTP hydrolysis and translocation (Wool et al., 1992). This
specific action of ribotoxins is so effective that a single
molecule of a-sarcin is enough to kill a cell (Lamy et al.,
1992). It was this unique potency and specificity against
ribosomes that prompted us to designate them as ‘natural
killers’.
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Ribosome-inactivating proteins (RIPs) are a group of
highly specialized toxic proteins (Stirpe et al., 1988, 1992;
Nielsen & Boston, 2001) produced by plants and fungi that
inactivate ribosomes by acting on the same unique rRNA
gene structure as ribotoxins do (Schindler & Davies, 1977;
Endo & Wool, 1982; Endo et al., 1987; Correll et al., 1998,
1999; Mears et al., 2002). Ribotoxins would be also RIPs
from this point of view, but some authors claim (Nielsen &
Boston, 2001; Peumans et al., 2001) that the name RIP
should be restricted to plant N-glycosidases, best repre-
sented by ricin, that depurinate a single nucleotide contig-
uous to the phosphodiester bond cleaved by ribotoxins
(Endo et al., 1987; Endo & Tsurugi, 1987). These are the
reasons why the conserved rRNA gene sequence targeted by
RIPs and ribotoxins has come to be universally known as the
sarcin–ricin loop, or SRL (Fig. 2).
Many prokaryotes encode both a labile antitoxin and a
stable toxin under the control of a single operon. These
toxin–antitoxin (TA) systems constitute another interesting
family of toxic endo-RNases (Christensen et al., 2003;
Mun˜oz-Go´mez et al., 2005; Condon, 2006; Kamphuis et al.,
2006; Luna-Cha´vez et al., 2006). The antitoxin is synthesized
in equimolecular amounts to the toxin, thus inhibiting its
ribonucleolytic action. Once the cells are under a variety of
stress conditions, the antitoxin is inactivated and the action
of the toxin promotes cellular growth arrest in preparation
for a more favorable situation. The target of these proteins is
not completely established, but mRNA seems to be the best
candidate according to the data so far published. It cannot
be ruled out, however, that the ribosome, or most probably
the translation complex, exerts some type of stimulating or
modulating activity (Christensen & Gerdes, 2003). Thus,
these endo-RNases can also be considered as modulators of
protein biosynthesis and, in this regard, they have a func-
tional connection with fungal ribotoxins. Actually, they
share cleavage mechanisms, as they also behave as cyclizing
Fig. 1. (a) Photograph of a culture of Aspergillus giganteus MDH
18894. (b) Three-dimensional structure of a-sarcin (PDB ID 1DE3):
The diagram was generated with the molmol program (Koradi et al.,
1996).
Fig. 2. (a) Diagram showing the structure of
the Halobacterium marismortui ribosome large
subunit (PDB ID 1JJ2): black, 23S RNA gene; cyan,
5S RNA gene; blue, SRL; red, ribosomal protein
L3; green, ribosomal protein L6; yellow, riboso-
mal protein 10e; purple, ribosomal protein L14;
gray, other ribosomal proteins. (b) Diagram
showing the structure of the SRL (Correll et al.,
1998). Numbers correspond to rat or Escherichia
coli (in brackets) nucleotide positions within the
28S (23S) rRNA gene. The bond cleaved by
ribotoxins is that on the 30-side of G4325 (2661)
(dark green). Ricin depurinates A4324 (2660)
(dark green). The bulged G is G4319 (2655)
(orange). The Watson–Crick region of the hairpin
(violet), the flexible region (cyan), the G-bulged
cross-strand stack (yellow) and the tetraloop
(green) are colored. The diagrams were
generated with the molmol program (Koradi
et al., 1996).
FEMS Microbiol Rev 31 (2007) 212–237 c 2007 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
213Fungal ribotoxins
RNases, as ribotoxins do (see below). However, the simila-
rities end there, as known ribotoxins are not produced by
prokaryotes, and use a different pair of side chain residues
for the acid–base catalysis, and no specific antitoxin produc-
tion has been so far reported (Martı´nez-Ruiz et al., 1998,
2001; Kamphuis et al., 2006).
In addition to their ribonucleolytic activity, ribotoxins
cross lipid membranes in the absence of any known protein
receptor (On˜aderra et al., 1993; Gasset et al., 1994;
Martı´nez-Ruiz et al., 2001). Thus, although any ribosome
could be potentially inactivated by these proteins, owing to
the universal conservativeness of the SRL, they are especially
active on transformed or virus-infected cells (Olson et al.,
1965; Ferna´ndez-Puentes & Carrasco, 1980; Olmo et al.,
2001). This observation has been explained in terms of
altered permeability of these cells combined with the ability
of ribotoxins to interact with acid phospholipid-containing
membranes (Gasset et al., 1989, 1990; Martı´nez-Ruiz et al.,
2001; Olmo et al., 2001).
a-Sarcin, restrictocin and Aspf1 are the most exhaustively
characterized ribotoxins (Arruda et al., 1992; Gasset et al.,
1994; Wool, 1997; Kao et al., 2001; Martı´nez-Ruiz et al.,
2001; Garcı´a-Ortega et al., 2005), but many others have been
identified and partially characterized in different fungal
species (Lin et al., 1995; Parente et al., 1996; Huang et al.,
1997; Wirth et al., 1997; Martı´nez-Ruiz et al., 1999a, b).
These studies have suggested a high degree of conservation
among ribotoxins, as those characterized display amino acid
sequence similarities above 85% (Fig. 3). However, hirsutel-
lin A (HtA), an extracellular ribonucleolytic protein pro-
duced by the invertebrate fungal pathogen Hirsutella
thompsonii, has been recently demonstrated to be a ribotox-
in (Herrero-Gala´n et al., 2007), and it displays only about
25% sequence identity with previously known family mem-
bers (Boucias et al., 1998; Martı´nez-Ruiz et al., 1999a;
Herrero-Gala´n et al., 2007). This suggests that the presence
of ribotoxins among fungi is more widespread than initially
considered (Martı´nez-Ruiz et al., 1999b). A specific RNase
purified from mature seeds of oriental arbovitae (Biota
orientalis) has also been reported to cleave a single phos-
phodiester bond of 28S rRNA gene in rat ribosomes but in a
different region from the SRL, although spatially close to it
(Xu et al., 2004).
Aspergilli are a ubiquitous and complex group of fila-
mentous fungi containing more than 185 species, including
20 human pathogens as well as others used for the industrial
production of foods and enzymes. The publication of the
genome sequence of the model organism Aspergillus nidu-
lans (Galagan et al., 2005) has created huge expectations
regarding advances in our knowledge of the biology of these
microorganisms. A comparative genomic study involving
two other species, Aspergillus fumigatus and Aspergillus
oryzae (Machida et al., 2005; Nierman et al., 2005), has also
been reported. Aspergillus nidulans does not produce any
ribotoxin, whereas A. fumigatus, a serious human pathogen,
produces Aspf1, one of the best known ribotoxins (Moser
et al., 1992). Aspergillus oryzae (Machida et al., 2005) is used
in the production of sake, miso and soy sauce, and also of
Fig. 3. (a) Sequence alignment of several different ribotoxins (a-sarcin, gigantin, clavin, restrictocin, and HtA) and RNases T1 and U2. Cysteine residues
of ribotoxins (blue) and the three proved, or presumed, catalytic residues of all the proteins (in red) are indicated. Diagrams showing the three-
dimensional structures of a-sarcin, restrictocin and RNases T1 and U2 are also shown. Color codes are as in Fig. 1. Three-dimensional structures of
proteins were fitted to the atomic coordinates of the active site residues (a-sarcin: 48, 50, 96, 121, 137, 145; restrictocin: 47, 49, 95, 120, 136, 144;
RNase T1: 38, 40, 66, 77, 92, 100; RNase U2: 39, 41, 62, 85, 101, 110) and common disulfide bridges of the four proteins (a-sarcin, 6–148; restrictocin,
5–147; RNase T1, 6–103; RNase U2, 9–113) (root mean square deviation of the fitting, 1.877). The diagrams and fittings were generated with the
molmol program (Koradi et al., 1996).
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RNase T1 (Sato & Egami, 1957), one of the most exhaus-
tively characterized proteins. RNase T1 is indeed the best
known member of the family of fungal extracellular RNases
(Yoshida, 2001; Loverix & Steyaert, 2001), a group that
obviously includes ribotoxins. All of them show a high
degree of sequence (Sato & Uchida, 1975; Sacco et al., 1983;
Martı´nez-Ruiz et al., 1999a, b) and structural similarity
(Pace et al., 1991; Noguchi et al., 1995; Yang & Moffat,
1996; Campos-Olivas et al., 1996a, b; Pe´rez-Can˜adillas et al.,
2000) (Fig. 3), but, apart from ribotoxins, none of these
RNases has been reported to show cytotoxic activity.
Besides RNase T1, RNase U2 from Ustilago sphaerogena
(Fig. 3) (Arima et al., 1968a, b; Sato & Uchida, 1975) also
stands out as the nontoxic microbial extracellular RNase most
closely related to ribotoxins from a phylogenetic point of view
(Sacco et al., 1983; Martı´nez del Pozo et al., 1988; Martı´nez-
Ruiz et al., 1999a, b, 2001). RNase U2 is a small and highly
acidic protein that shows a strong preference for 30-linked
purine nucleotide phosphodiester linkages (Rushizky et al.,
1970; Uchida et al., 1970), which is rather unusual within the
group of microbial RNases. RNase T1, for example, shows
strict specificity for the guanyl group. Both enzymes also
differ in their optimum pH values, which are acid for RNase
U2 and neutral for RNase T1, but both are cyclizing enzymes,
cleaving RNA in two separate steps, transphosphorylation
and hydrolysis (Yasuda & Inoue, 1982).
Ribotoxins are larger proteins, generally basic, that con-
tain longer and charged loops that are not present in the
noncytotoxic fungal RNases (Fig. 3), suggesting that these
loops are the structural basis of their toxicity (Martı´nez del
Pozo et al., 1988). It would appear that an RNase T1-like
RNase had acquired ribosome specificity by the insertion of
short recognition domains that would target it to cleave
more specific substrates. Thus, the study of the evolution
and mechanism of action of ribotoxins is of particular
interest, as they appear to be naturally engineered targeted
toxins evolved from the other microbial nontoxic RNases to
enter cells and specifically inactivate the ribosomes (Lamy
et al., 1992; Kao & Davies, 1995). Identification of the
structural features that have allowed these proteins to
become such efficient natural killers would be a major step
towards their utilization, native or modified, as weapons
against different human pathologies.
Structural features
Ribotoxins are synthesized as precursors that mature into
cellular membrane compartments (Endo et al., 1993a, b).
Consequently, there has been speculation for a long time
about the mechanism developed by the producing fungi in
order to overcome the toxicity of these proteins, as their own
ribosomes are also sensitive to the action of the toxins
(Miller & Bodley, 1988). There is no evidence for the
simultaneous production of any antitoxin or protein inhi-
bitor that could block their cytotoxic action before they are
secreted to the extracellular medium (Martı´nez-Ruiz et al.,
1998b), as happens with some bacterial ribonucleolytic
toxins (Mun˜oz-Go´mez et al., 2005; Condon, 2006; Kam-
phuis et al., 2006; Luna-Cha´vez et al., 2006). In addition,
characterization of pro-a-sarcin, produced in Pichia pas-
toris, revealed that it is ribonucleolytically active (Martı´nez-
Ruiz et al., 1998). Thus, the data so far accumulated suggest
that protection of the producing cells against the toxic
effects of ribotoxins must rely on efficient recognition of
their signal sequences, followed by adequate compartmen-
talization before they are secreted to the extracellular
medium.
The complete or partial amino acid sequences of several
ribotoxins have been determined (Rodrı´guez et al., 1982;
Sacco et al., 1983; Lo´pez-Otı´n et al., 1984; Ferna´ndez-Luna
et al., 1985; Arruda et al., 1990; Wirth et al., 1997; Martı´nez-
Ruiz et al., 1999a, b). They show a high degree of identity in
their c. 150 amino acid sequence (Fig. 3), including the
conservation of their two disulfide bridges (Martı´nez
del Pozo et al., 1988; Martı´nez-Ruiz et al., 2001). This
observation includes HtA (Martı´nez-Ruiz et al., 1999a),
although it is 20 residues shorter than the other known
ribotoxins. Sequence differences are mainly concentrated at
the loops of the ribotoxins (Martı´nez-Ruiz et al., 1999a)
(Fig. 3).
This similarity is also manifested in the three-dimen-
sional structure of the two ribotoxins studied at this level,
restrictocin (Yang & Moffat, 1996; Yang et al., 2001) and a-
sarcin (Pe´rez-Can˜adillas et al., 2000, 2002; Garcı´a-Mayoral
et al., 2005a, b). For a-sarcin, nuclear magnetic resonance
(NMR) and other techniques have been used to make a very
detailed map of its structural and dynamic properties
(Campos-Olivas et al., 1996a, b; Pe´rez-Can˜adillas et al.,
2000, 2002; Garcı´a-Mayoral et al., 2005a, b). The elucidation
of its three-dimensional structure (Fig. 1) revealed that it
folds into an a1b structure with a central five-stranded
antiparallel b-sheet and an a-helix of almost three turns.
The sheet is composed of the strands b3, b4, b5, b6 and b7
arranged in a  1,  1,  1,  1 topology (Figs 1 and 3)
(Campos-Olivas et al., 1996a, b; Pe´rez-Can˜adillas et al.,
2000). It is highly twisted in a right-handed sense, defining
a convex face against which the a-helix is orthogonally
packed, and a concave surface that holds the active site
residues His50, Glu96, Arg121 and His137, with their side
chains projecting outwards from the cleft (Fig. 4). In
addition, residues 1–26 form a long b-hairpin that can be
considered as two consecutive minor b-hairpins connected
by a hinge region. The first one is closer to the open end of
the hairpin, whereas the second sub-b-hairpin is formed by
two short strands b1b and b2b connected by a type I b-turn.
This last part of the N-terminal hairpin juts out as a solvent-
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exposed protuberance, a detail that it is important for its
function, as explained below. a-Sarcin and restrictocin show
almost identical structures (Fig. 3), but some small differ-
ences are observed concerning their long nonstructured
loops and especially the above-mentioned N-terminal b-
hairpin, a region of high mobility (Pe´rez-Can˜adillas et al.,
2002), which is lacking in the restrictocin crystalline struc-
ture (Yang & Moffat, 1996). The remaining stretches of its
sequence form large loops connecting the secondary struc-
ture elements (Fig. 1). Despite the exposed character of these
loops and their lack of repetitive secondary structure, their
conformations are well defined. They are maintained by
networks of intraloop and interloop interactions, including
hydrogen bonds, hydrophobic interactions, and salt bridges
(Yang & Moffat, 1996; Pe´rez-Can˜adillas et al., 2000). From a
dynamic point of view, NMR measurements have shown
that a-sarcin behaves as an axial symmetric rotor of the
prolate type, and that it is composed of a rigid hydrophobic
core and some exposed segments, mostly the loops, which
undergo fast (picosecond to nanosecond) internal motions
(Pe´rez-Can˜adillas et al., 2002).
Ribotoxins share this structural core with nontoxic
RNases of the RNase T1 family, in good agreement with the
observed sequence similarity (Figs 3 and 4). For example,
comparison of the three-dimensional structures of a-sarcin
and restrictocin with those of RNase T1 and RNase U2
reveals that the four proteins share identical regular second-
ary structure elements despite their different amino acid
sequence lengths, including the geometric arrangement of
the residues involved in the active site (Figs 3 and 4). Thus,
all fungal extracellular RNases whose three-dimensional
structure is known exhibit quite different enzymatic specifi-
cities, but all of them share this common structural fold
concerning the architecture and connectivity of the second-
ary structure elements (Yang & Moffat, 1996; Campos-
Olivas et al., 1996b; Pe´rez-Can˜adillas et al., 2000; Martı´nez-
Ruiz et al., 2001). The most significant structural differences
among them are, again, related to both the presence of a
longer N-terminal b-hairpin in ribotoxins and the different
length and charge of their unstructured loops (Figs 3 and 4).
Loop 2 of a-sarcin (Thr53 to Tyr93) (Fig. 3) deserves
especial emphasis, because it exhibits a well-defined con-
formation with functional implications (Pe´rez-Can˜adillas
et al., 2000). It is highly mobile, rich in Gly and positively
charged residues, and largely solvent exposed. In this loop,
the stretch comprising residues 52–54 is essentially frozen
within the molecular framework (Pe´rez-Can˜adillas et al.,
2002), Asn54 being a conserved residue among fungal
extracellular RNases (Manchen˜o et al., 1995a) that estab-
lishes a hydrogen bond between its amide side chain proton
and the carbonyl group of Ile69, these protons being very
resistant to exchange with the solvent. This interaction is,
Fig. 4. Representation of the geometric
arrangement of the side chain residues found in
the active sites of a-sarcin and RNase T1. Only the
side chains of the catalytic residues directly in-
volved in the mechanism of general acid–base
cleavage are shown. The three-dimensional
structures of both proteins are also shown. The
diagrams were generated with the molmol pro-
gram (Koradi et al., 1996).
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indeed, conserved in the other RNases of the RNase T1
family (Sevcik et al., 1991; Pfeiffer et al., 1997, Hebert et al.,
1998). Docking studies have also suggested that the segment
formed by residues 51–55 of a-sarcin (Fig. 3) could specifi-
cally interact with the SRL in the vicinity of the scissile bond
(Pe´rez-Can˜adillas et al., 2000), a prediction that was later
confirmed by X-ray crystallography (Fig. 5a) (Yang et al.,
2001). In relation to this, three Lys residues of loop 3
(Lys111, Lys112 and Lys114) seem to be of especial impor-
tance, as they contact the identity element of the ribosomal
SRL region, the bulged-G in the S-turn (see below and Fig.
5a) (Yang &Moffat, 1996; Pe´rez-Can˜adillas et al., 2000; Yang
et al., 2001).
It is also remarkable that an N-terminal deletion mutant
D(7–22) of a-sarcin (Garcı´a-Ortega et al., 2002) retained the
same conformation as the wild-type protein, as ascertained
from its spectroscopic characterization (Garcı´a-Ortega et al.,
2002) and three-dimensional structure in solution (Garcı´a-
Mayoral et al., 2004). Docking and enzymatic studies have
revealed that this N-terminal b-hairpin (positions 7–22) of
a-sarcin could establish interactions with ribosomal pro-
teins in order to direct the ribotoxin to the SRL region of the
ribosome (Garcı´a-Ortega et al., 2002; Garcı´a-Mayoral et al.,
2005b) (Fig. 5).
a-Sarcin is a highly charged protein, with a high iso-
electric point. The high content of positively charged
residues is probably required for recognizing and binding
to not only its highly negatively charged target, the rRNA
gene, but also the cellular membranes. It contains eight Tyr
and two Trp residues, which have been spectroscopically
explored. By using UV absorbance, fluorescence emission
and circular dichroism (CD) measurements, five different
pH-induced conformational transitions, corresponding to
pKa values of 2.5, 4.5, 8.0, 10.2, and 11.4, were initially
described (Martı´nez del Pozo et al., 1988). The two latter
ones (10.2 and 11.4) corresponded to two different Tyr
populations of different solvent accessibility. The transition
at pKa 8.0 was assigned to the a-amino group of the N-
Fig. 5. (a) Diagram showing the crystalline struc-
ture of an SRL analog–restrictocin complex (Yang
et al., 2001) (PDB accession number 1JBS). The
analog structure is distorted in comparison to the
wild-type SRL, and this explains the absence of
cleavage, which allowed crystallization of the
complex. The side chains of His49 (blue), Glu95
(red), and His136 (red) are also shown. The RNA
backbone is shown is black, with the bases in
gray, except for the bulged G in yellow, the
tetraloop in green, and the phosphate group of
the bond susceptible to cleavage in magenta. The
loops equivalent to a-sarcin’s loops 2, 3 and 5 are
also indicated. (b) Diagram showing the a-sarcin
regions presumably involved in the establishment
of interactions with phospholipid bilayers: purple,
residues 7–22; orange, residues 116–139 and 51;
red, residues 53–93 (loop 2). The side chains of
Trp51, Arg121 and His137 are also shown.
(c) Minimized docking model showing the inter-
action of wild-type (PDB ID 1DE3) and D(7–22)
a-sarcin (PDB ID 1R4Y) with the SRL (PDB ID
430D) and the Halobacterium marismortui
ribosomal proteins L6 and L14 (Garcı´a-Mayoral
et al., 2005a, b). Diagrams were generated
with molmol (a, c) (Koradi et al., 1996) and
vmd (b) (Humphrey et al., 1996) programs.
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terminal residue, Asp and Glu residues deprotonated at pH
4.5, and pKa values of 2.5 and 10.2 were considered to be
denaturing transitions (Martı´nez del Pozo et al., 1988). This
characterization later became much more detailed, when the
pKa values of all aspartic acid, glutamic acid and histidine
residues of a-sarcin were determined by NMR; it was found
that many of them, including several at the active site, are
highly perturbed (Pe´rez-Can˜adillas et al., 1998). Much more
recently, the pKa values of all titratable residues have also
been systematically measured, or predicted when direct
measurement was not possible because of the unfolding of
the protein (Garcı´a-Mayoral et al., 2003). These measure-
ments and predictions were also extended to a series of
active site variants (E96Q, H50Q, H137Q, and H50/137Q)
(Garcı´a-Mayoral et al., 2003, 2006). This detailed character-
ization at the level of individual residues was completed by
determining the tautomeric state of all the side chain
histidine residues (Pe´rez-Can˜adillas et al., 2003).
a-Sarcin’s two Trp residues, at positions 4 and 51, are
conserved in all ribotoxins known so far (Fig. 3). Character-
ization of mutants where one or both of these two residues
were substituted by Phe (single mutants W4F and W51F, and
the double mutant W4/51F) showed that they are not
required for the highly specific ribonucleolytic activity of the
protein, although the mutant forms involving Trp51 showed
decreased activity (De Antonio et al., 2000). More impor-
tantly, it was shown that Trp51 is responsible for most of the
near-UVCD of the protein, and also contributes to the overall
ellipticity of the protein in the peptide bond region, but does
not show fluorescence emission (De Antonio et al., 2000).
Finally, it is also important, from a structural point of
view, to mention that the active site of a-sarcin is composed
of at least residues Tyr48, His50, Glu96, His137, Arg121, and
Leu145, although only three of them (His50, Glu96, and
His137) are directly involved in proton transfer steps in the
catalytic mechanism (Lacadena et al., 1999; Martı´nez-Ruiz
et al., 2001). As mentioned above, they are located in the
central b-sheet, and their side chains point towards the
concave face of the protein structure (Fig. 4). The most
representative characteristics of this active site would be: (1)
high density of charged residues; (2) unusual pKa values of
His50, Glu96, and His137; (3) unusual Nd tautomeric forms
adopted by His50 and His137, a common feature of micro-
bial RNases; (4) the presence of a structurally important
hydrogen bond between the catalytic His137 and a backbone
oxygen in loop 5; and (5) low surface accessibility of all
titratable atoms (Pe´rez-Can˜adillas et al., 1998, 2000, 2003).
Crossing membranes
The antitumor activity of a-sarcin can be explained by its
unique ribonucleolytic activity after its selective passage
across some cell membranes. Thus, although the SRL is a
universally conserved structure, cells are only killed if
ribotoxins cross their membranes to gain access to the
ribosomes. As no protein receptors have so far been reported
for a-sarcin, the toxic specificity must be related to a
differential interaction with the lipid components of the
membranes. Long ago, it was shown that a-sarcin was a
powerful inhibitor of protein synthesis in picornavirus-
infected cells (Ferna´ndez-Puentes & Carrasco, 1980), and
that ionophores (Alonso & Carrasco, 1981, 1982), external
ATP (Otero & Carrasco, 1986) or phospholipase C treat-
ment (Otero & Carrasco, 1988) targeted mammalian cells to
a-sarcin entry. All these observations were interpreted in
terms of the existence of altered membrane permeability.
The use of lipid model systems proved that a-sarcin
interacts specifically with negatively charged phospholipid
vesicles at neutral or slightly acidic pH, resulting in pro-
tein–lipid complexes that can be isolated by centrifugation
in a sucrose gradient (Gasset et al., 1989). Binding experi-
ments revealed a strong ribotoxin–lipid vesicle interaction
(Kd = 60.0 nM) that caused vesicle aggregation, followed by
their fusion into much larger lipidic structures (Gasset et al.,
1989). The minimum phosphatidylcholine/phosphatidyl-
glycerol molar ratio required for this behavior was 1 : 10,
and it was dependent on neither the length nor the degree of
unsaturation of the phospholipid acyl chain, being more
effective at temperatures above the melting temperature of
the phospholipid used. Saturation was reached at phospho-
lipid/protein molar ratios of 50 : 1, and the effect was
maximal at 0.15M ionic strength. It was, however, abolished
at basic pH (Gasset et al., 1990).
Light-scattering stopped-flow kinetic studies of the a-
sarcin–vesicle interaction revealed that the initial step was
the formation of a vesicle dimer maintained by protein–-
protein bridges (Manchen˜o et al., 1994). Once the aggrega-
tion had started, lipid mixing occurred between the bilayers
of aggregated vesicles, as would be expected with fusing
liposomes. In fact, this fusion was triggered by the destabi-
lizing effect of the protein, which simultaneously suffered
conformational changes upon binding to the vesicles (Man-
chen˜o et al., 1994), as revealed by CD, fluorescence emission,
and attenuated total reflection Fourier transform infrared
spectroscopy (ATR-FTIR) (Gasset et al., 1991b). These
conformational changes suggested an increase in the a-helix
content that, together with the other spectroscopic changes
observed, was interpreted in terms of shielding from polar
groups caused by the lipids, which would promote intra-
chain hydrogen bonding and decreased static quenching
(Gasset et al., 1991b). Indeed, the peptide bonds of the
protein were protected against trypsin hydrolysis upon
binding to these vesicles (Gasset et al., 1989; On˜aderra
et al., 1989), despite the high number of basic residues
present along its sequence (Sacco et al., 1983). Freeze-
fracture electron micrographs corroborated this fusogenic
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effect, as at the highest phospholipid/protein molar ratio
employed (50 : 1), there was a complete absence of small
vesicular structures; instead, lipids were exclusively orga-
nized in planar sheets, indicating that the fusion processes
had gone to completion (Gasset et al., 1990). As a final step,
and most probably as a consequence of the formation of
these unstable large structures, a-sarcin also modified the
permeability of the membranes, causing the leakage of
calcein in dye-trapped phosphatidylglycerol vesicles (Gasset
et al., 1990). Fluorescence depolarization measurements,
differential scanning calorimetry and labeling with photo-
active phospholipids revealed that a-sarcin, a water-soluble
and hydrophilic protein, interacts with phospholipid bi-
layers through a combination of electrostatic and hydro-
phobic forces (Gasset et al., 1991a). According to this
hypothesis, the protein would then initially be adsorbed to
the charged polar head groups of the phospholipids, and
then would partially penetrate the interface of the bilayer to
interact with a portion of the lipid hydrocarbon chains
(Gasset et al., 1991a). All these observations were consistent
with an intercalation of the protein into the lipid matrix,
promoting fusion and permeability changes in the bilayers,
processes that would presumably be involved in the
passage of the protein across the membranes of its target
cells. A higher content of negatively charged phospholipids,
such as phosphatidylserine, has been reported in trans-
formed cell membranes (Connor et al., 1989; Gasset et al.,
1989, 1990; Zachowski, 1993). Unfortunately, there is no
direct evidence yet that this abundance of acidic phospholi-
pids is the main explanation for the antitumor activity
of a-sarcin.
In good agreement with this hypothesis, the innate ability
of a-sarcin to translocate across a phospholipid membrane,
if it is acidic enough, in the absence of any other protein was
also demonstrated, using two different types of assay
(On˜aderra et al., 1993). First, the protein was completely
degraded when added externally to asolectin vesicles con-
taining encapsulated trypsin, an experiment that was per-
formed in the presence of such an external excess of trypsin
inhibitor that degradation by traces of leaked protease was
not possible. Second, externally added a-sarcin was also
capable of cleaving encapsulated baker’s yeast tRNA mole-
cules in a protein concentration-dependent manner
(On˜aderra et al., 1993).
With regard to the protein regions involved in the
interaction, the first hints were obtained using water-soluble
synthetic peptides corresponding to sequences within the
main b-sheet of a-sarcin. Some of these peptides, one of
them only nine residues long, were shown to be able to
mimic, at least qualitatively, the effects produced by the
complete protein on acid phospholipid vesicles, indicating
that this region of the protein (residues 116–139) is probably
involved in its interaction with the cell membranes (Fig. 5b)
(Manchen˜o et al., 1995b, 1998a). These conclusions were
indeed compatible with the observation that a denatured
form of a-sarcin, containing b-strands as the only regular
secondary structure elements, promoted destabilization of
the hydrophobic core of bilayers (Gasset et al., 1995). Using
the Trp mutants mentioned above, it was also shown that
neither Trp4 nor Trp51 were required for the interaction of
a-sarcin with lipid membranes (aggregation and fusion of
vesicles) (De Antonio et al., 2000). However, this interaction
promoted a large increase in the quantum yield of Trp51, the
residue located in the b-sheet of the protein (Fig. 5b), and its
fluorescence emission was simultaneously quenched by
anthracene incorporated into the hydrophobic region of
such bilayers. Furthermore, a study of mutants affecting a-
sarcin active site residue Arg121 (R121 K and R121Q), also
located at the major b-sheet (Figs 4 and 5b), showed that the
loss of the positive charge at that position produced a
dramatic impairment of the protein’s ability to interact with
phospholipid membranes (Masip et al., 2001). This inter-
esting result led to the proposal that proteins that had
evolved to interact with RNA, such as ribotoxins, would
have developed structural and chemical determinants to
recognize polyphosphate lattices that might, indeed, allow
the recognition of a phospholipid bilayer (Masip et al.,
2001). Interestingly, when the crystalline structure of re-
strictocin was solved, the equivalent residue (Arg120) was
found to be hydrogen bonded to a cocrystallized phosphate
molecule at its active site (Yang & Moffat, 1996). In
summary, these results indicated that this b-sheet, predicted
to be one of the scarcest apolar regions of the protein
(Martı´nez del Pozo et al., 1988; Manchen˜o et al., 1995b),
was in fact located within the hydrophobic core of the
bilayer following protein–vesicle interaction (Fig. 5b) (De
Antonio et al., 2000).
Other than this hydrophobic core, mutations affecting
single residues located at the N-terminal b-hairpin of a-
sarcin (Lys11 and Thr20) and the deleted D(7–22) variant
suggested that this protein portion would be another region
involved in the interaction with cell membranes (Garcı´a-
Ortega et al., 2001, 2002), as they displayed a different
pattern of interaction with the lipid vesicles (Fig. 5b). When
restrictocin was the protein assayed, it also behaved differ-
ently fromwild-type a-sarcin (Garcı´a-Ortega et al., 2001). It
is noteworthy that a-sarcin and restrictocin sequences differ
in only 20 residues, and six of these changes are concentrated
at the N-terminal b-hairpin (Fig. 3). In agreement with this
idea, the D(7–22) a-sarcin showed behavior compatible with
the absence of one vesicle-interacting protein region
(Garcı´a-Ortega et al., 2002).
Finally, loop 2 has been proposed by several authors
(Yang & Moffat, 1996; Martı´nez del Pozo et al., 1988; Kao
& Davies, 1999; Pe´rez-Can˜adillas et al., 2000) to also be one
of the protein regions involved in the interaction with lipids
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(Fig. 5b). The differences between the NMR-refined struc-
ture of this loop in a-sarcin and restrictocin (Garcı´a-
Mayoral et al., 2005a, b) could help to explain their distinct
behavior when translocating across cell membranes,
although this possibility has not been directly studied yet.
Enzymatic properties
The enzymatic activity of ribotoxins remained obscure for a
long time after their discovery (Lamy et al., 1992). Then, in
1977, Schindler and Davies published the observation that
a-sarcin was able to inactivate both Saccharomyces cerevisiae
and Escherichia coli ribosomes, although with different
efficiencies (Schindler & Davies, 1977). Surprisingly, neither
intact yeast or bacteria nor HeLa cells were susceptible to the
toxicity exerted by a-sarcin, suggesting that they were
refractory to the entrance of the protein. A more detailed
study concluded that a-sarcin’s inactivation of purified
ribosomes affected EF-2-catalyzed GTP hydrolysis and
translocation. Finally, separation of the rRNA gene species
by gel electrophoresis after incubation of yeast 80S ribo-
somes with the toxin resulted in the appearance of an extra
fragment about 300 nucleotides long (the so-called a-
fragment), corresponding to the 30-end of the 28S rRNA
gene (Fig. 6a) (Schindler & Davies, 1977). Further experi-
ments showed that a-sarcin cleaved the phosphodiester
backbone at the 30-side of G2661 (E. coli numbering) (Endo
& Wool, 1982), whereas ricin depurinated the N-glycosidic
linkage between the ribose sugar and the base moieties
corresponding to the 50-adjacent A2660 (both positions
corresponding to G4325 and A4324 in 28S rRNA gene)
(Fig. 2) (Endo & Tsurugi, 1987; Endo et al., 1987).
Therefore, ribotoxins are highly specific RNases against
cell-free intact ribosomes, and they retain this specificity
when assayed against naked rRNA gene containing the
SRL. However, they can also cause extensive progressive
digestion of total or 28S rRNA with no formation of the a-
fragment, when used at higher concentrations (Endo et al.,
1993a, b; Wool, 1996, 1997). Even DNA has been shown to
be digested by a-sarcin when large enzyme/substrate ratios
are assayed (Wool, 1984; Endo et al., 1993a, b). This
nonspecific activity has been taken advantage of in the
employment of some other, much less specific, ribonucleo-
lytic assays, apart from those based on following the release
of the a-fragment. The lack of biological significance, due to
the loss of specificity, and the much higher than catalytic
concentrations needed, are compensated for by much easier
quantitation of the results, as well as the possibility of
analyzing the products, or even intermediates, of the reac-
tion. Thus, although they are less specific, these assays have
contributed significantly to the detailed study of the cleavage
mechanism of ribotoxins (Lacadena et al., 1994, 1998; Kao
et al., 2001; Martı´nez-Ruiz et al., 2001).
Four different types of enzymatic assay are usually
performed (Kao et al., 2001; Martı´nez-Ruiz et al., 2001).
The first, and most specific, is one that uses natural
substrates, purified ribosomes or, at least, a cell-free reticu-
locyte lysate (Kao et al., 2001). The highly specific action can
be then visualized by detecting the release of a 300–400-
nucleotide (depending on the ribosome source) a-fragment
on a denaturing agarose gel stained with ethidium bromide
(Fig. 6a). The sensitivity of this assay has recently been
improved by the detection of this a-fragment by hybridiza-
tion with a specific 32P-radiolabeled DNA probe (Korennykh
et al., 2006).
In decreasing order of complexity, and therefore of
specificity, the second assay frequently used is based on the
Fig. 6. Examples of the different enzymatic assays used to study
ribotoxin ribonucleolytic activity. The presence (1) or absence ( ) of a-
sarcin in the assay is indicated. (a) Specific cleavage of rabbit ribosomes.
The a-fragment is indicated by an arrow. (b) Specific cleavage of a 35-
mer SRL-like oligonucleotide. (c) Zymogram against poly(A). (d) HPLC
resolution of the products produced after incubation of a-sarcin with
ApA.
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employment of short oligoribonucleotides mimicking the
SRL sequence and structure (SRL-like oligos). Ribotoxins
cleave these SRL-like oligos specifically, producing only two
smaller fragments, which can be fractionated on a polyacry-
lamide gel (Fig. 6b) (Endo et al., 1988; Wool et al., 1992),
although this cleavage is several orders of magnitude less
efficient than that produced on intact ribosomes (Glu¨ck &
Wool, 1996; Wool, 1997).
The third, and much less specific, assay is a zymogram
(Fig. 6c), in which the ribonucleolytic activity is shown
against a homopolymer, such as poly(A) or poly(I), em-
bedded in a polyacrylamide gel after electrophoretic separa-
tion of the proteins by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and con-
venient refolding by elimination of the detergent. In some
instances, this type of assay can be also performed in
solution, using ultrafiltration devices to fractionate the small
oligonucleotides produced by the ribonucleolytic reaction
(Kao et al., 2001). The advantage of the zymogram is its
additional use as a homogeneity control of the protein
sample.
The fourth assay is based on the fact that ribotoxins are
also capable of hydrolyzing different dinucleoside (or dinu-
cleotide) phosphates, such as ApA (or ApAp), although with
very low efficiency (Lacadena et al., 1998). This type of
substrate should be considered as just containing the mini-
mal and essential elements needed to be cleavable by a
RNase. The advantage in this case is that the products,
substrates and intermediates of the reaction can be separated
and quantitated by HPLC (Fig. 6d), providing information
about the different steps (Lacadena et al., 1998).
A combination of all these different activity assays, and
the production and characterization of many site-directed
and randomly produced mutants (Yang & Kenealy, 1992a, b;
Lacadena et al., 1995, 1999; Kao et al., 1998), have allowed
the determination of not only the ribotoxin residues in-
volved in the catalytic reaction, but also their different roles
during the cleavage of a phosphodiester bond. The non-
cytotoxic microbial RNases T1 and U2 have been of great
help as reference models. The enzymatic mechanism of
RNase T1, for example, has been clearly established (Fig. 7),
as have the roles of most of the residues forming its active
site (Steyaert, 1997; Loverix & Steyaert, 2001; Yoshida,
2001). Accordingly, this enzyme performs the general acid–-
base type endonucleolytic cleavage of RNA in two steps.
First, there is a transphosphorylation reaction to form a
20,30-cyclic phosphate intermediate. Second, this intermedi-
ate is hydrolyzed to the corresponding 30-phosphate (Fig. 7).
The appearance of this cyclic intermediate, common to all
RNases of the RNase T1 family so far studied, including
RNase U2, is implicit in the denomination of all these
enzymes as cyclizing RNases. Analysis of the cleavage reac-
tions performed by a-sarcin against different dinucleoside
monophosphates proved that this protein is also a cyclizing
RNase (Lacadena et al., 1998, 1999), with an optimum pH of
5.0 (Pe´rez-Can˜adillas et al., 1998; Lacadena et al., 1999).
Therefore, ribotoxins follow the same general reaction
scheme as the other members of the RNase T1 family.
However, the catalytic efficiency of RNases T1 and U2
against naked RNA, homopolynucleotides or dinucleotides
is several orders of magnitude higher. On the other hand,
when assayed against natural substrates, ribotoxins cleave
and consequently inactivate the ribosome with a second-
order rate constant (kcat/Km of 1.7 1010M1 s1) that
matches the catalytic efficiency of the fastest known enzymes
(Korennykh et al., 2006).
In the case of RNase T1, during the first step of the
reaction Glu58 acts as a general base and His92 as a general
acid (Figs 4 and 7). The hydrolysis of the cyclic derivative is
catalyzed by the same groups, but their roles are reversed
(Steyaert, 1997). In fact, the most common pair of catalytic
residues found in microbial RNases is this Glu/His combi-
nation (Yoshida, 2001). Another His residue, His40, is
required in its protonated form to assist the electrostatic
stabilization of the transition state and, eventually, seems to
be able to adopt the function of the general base, as shown
Fig. 7. Proposed mechanism for the catalytic
mechanism of cyclizing RNases against a dinu-
cleotide substrate (ApA or GpA). A transpho-
sphorylation process (in which the corresponding
20,30 cyclic mononucleotide and adenosine are
produced) is followed by hydrolysis of the cyclic
nucleotide to produce the corresponding 30-
mononucleotide. (A), (B) and (C) are His92, Glu58
and His40 in RNase T1 (Steyaert, 1997), and
His137, Glu96 and His50 in a-sarcin (Lacadena
et al., 1999), respectively.
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with Glu58-mutated variants of RNase T1 (Steyaert et al.,
1990; Steyaert, 1997). Superposition of the three-dimen-
sional structures of RNases T1 and U2 with those of a-sarcin
and restrictocin showed that the counterpart residues were
a-sarcin’s His137, Glu96, and His50, and restrictocin’s
His136, Glu95, and His49 (Fig. 4) (Sacco et al., 1983;
Martı´nez del Pozo et al., 1988; Campos-Olivas et al.,
1996b). Production of wild-type and several mutant forms
of restrictocin in S. cerevisiae showed that only the strain
producing an H136L mutant was able to grow (Yang &
Kenealy, 1992a, b). The same authors produced and partially
characterized this same mutant in A. niger and A. nidulans
(Brandhorst et al., 1994), with very similar results. Not
much later, another equivalent a-sarcin (H137Q) and
restrictocin (H136Y) variants were isolated and character-
ized in detail from the structural and functional points of
view; this confirmed that their lack of toxicity was due to the
absence of ribonucleolytic activity, and not to major con-
formational changes (Kao & Davies, 1995; Lacadena et al.,
1995). Thanks to the production and further characteriza-
tion of more mutants, affecting these three residues in a-
sarcin and restrictocin, it is now well known that a-sarcin
His137 and Glu96 are the only residues that are essential for
performing the acid–base type reaction (Brandhorst et al.,
1994; Kao & Davies, 1995, 1999; Lacadena et al., 1995, 1999;
Sylvester et al., 1997; Kao et al., 1998); His50 would also
contribute to the stabilization of the transition state but, in
this case, would not be able to substitute for Glu96 as the
general base in E96Q mutants (Fig. 7) (Lacadena et al.,
1999). This was inferred because substitution of His50 (or
His49 in restrictocin) with different residues did not com-
pletely inactivate the enzyme, but rather decreased its kcat
values, so that it showed only residual enzymatic or cyto-
toxic activity, depending on the nature of the assay used
(Nayak & Batra, 1997; Sylvester et al., 1997; Lacadena et al.,
1999). In addition, it was proved that the three mentioned
residues are required for the specific inactivation of the
ribosomes, as each individual variant assayed, as well as the
double and triple mutant versions, lacked this particular
activity (Lacadena et al., 1999).
The profile obtained for the pH dependence of the a-
sarcin activity is typical for an acid–base catalyst but
significantly different from that described for RNases T1 or
U2 (Arima et al., 1968a, b; Sylvester et al., 1997; Pe´rez-
Can˜adillas et al., 1998; Lacadena et al., 1999). The a-sarcin
H50Q mutant also shows quite different behavior, probably
due to the absence of a positive charge in the Glu96
environment. Finally, whereas a-sarcin displays a low effi-
ciency in hydrolyzing the cyclic intermediate, as most
cyclizing RNases do, its H50Q variant is much more efficient
in producing the 30-AMP product at pH 7.0 (Lacadena et al.,
1999). The NMR measurements mentioned above were also
used to calculate how these active site residues display pKa
values far from their intrinsic values, which would explain
these different behaviors in terms not only of specificity but
also of pH dependence (Pe´rez-Can˜adillas et al., 1998;
Lacadena et al., 1999).
In the crystal complex of RNase T1 with the minimal
substrate 30-GMP (Loverix & Steyaert, 2001), Tyr38, Arg77
and Phe100 also appear to form the catalytic site of the
enzyme. There has been speculation about these three
residues, together with His40, forming a prearranged struc-
tural and dielectric microenvironment that is complemen-
tary in shape, charge and hydrogen-bonding capacity to the
equatorial oxygens of the transition state, contributing to its
optimal solvation/desolvation (Loverix & Steyaert, 2001).
Tyr48, Arg121 and Leu145 are their three corresponding
structural counterparts in a-sarcin (Figs 3 and 4), and
therefore have been also studied.
RNase T1 Arg77 is located in the vicinity of the substrate
phosphate moiety, but its potential functional role is not
known, as all attempts to isolate any RNase T1 with a
mutation affecting that residue have been unsuccessful
(Steyaert, 1997). Thus, it has long been proposed that Arg77
of RNase T1 might facilitate the nucleophilic attack, but this
has not been directly proven by site-directed mutagenesis
(Steyaert, 1997). On the other hand, Arg121 of a-sarcin has
been replaced by Gln or Lys, mutations that did not modify
the conformation of the protein, but abolished its ribosome-
inactivating activity. Unexpectedly, these mutants were still
active against a small and nonspecific substrate such as ApA
(similar Km and lower catalytic efficiency than the wild-type
protein) (Masip et al., 2001). In addition, as mentioned
above, the loss of the positive charge at that position
produced dramatic changes in a-sarcin’s ability to interact
with phospholipid membranes (Masip et al., 2001).
Regarding RNase T1 Phe100, a Leu residue (Leu145)
occupies the equivalent position in a-sarcin (Figs 3 and 4).
The side chain of Phe100 is an apolar catalytic element,
stabilizing charge separations that occur in the transition
state by controlling the dielectric environment (Doumen
et al., 1996). Characterization of an L145F variant of a-
sarcin revealed that it was still an active RNase (the mutant
exhibited a similar Km and slightly lower catalytic efficiency
against the ApA substrate), but displayed lower specificity
than the wild-type protein against rRNA gene and SRL-like
substrates (Masip et al., 2003). Leu145 was also shown to be
essential to preserve the electrostatic environment of the
active site required to maintain the anomalously low pKa
value reported for the catalytic His137 (Masip et al., 2003).
One of the residues showing the largest NMR chemical
shift variation in the L145F mutant of a-sarcin was Asn54, a
conserved residue located in loop 2 (Fig. 3). It not only
contributes to the high stability of ribotoxins, but is also
required for their highly specific action on ribosomes,
according to the results obtained after the characterization
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of five different a-sarcins with mutations at this position
(Siemer et al., 2004). These results suggest that Asn54 is
involved in local conformational arrangements at the sub-
strate-binding pocket. The mutations at this position re-
sulted in less efficient RNases, especially against nonspecific
substrates such as poly(A). The RNase residues involved in
the interaction with the base 50 to the cleaved phosphodie-
ster bond are usually referred as the base recognition
residues. The results obtained with the a-sarcin Asn54
mutants are in agreement with the idea that residues 53–56
(52–55 in restrictocin) would form that recognition pocket
in ribotoxins (Yang & Moffat, 1996). However, recognition
of ribosomes involves a much more complex network of
interactions, most of which would not be disturbed by the
mutation of Asn54, which would explain why most of the
mutants still retained the ability to specifically release the a-
fragment (Siemer et al., 2004). Overall, these results are in
perfect agreement with the idea of local conformational
rearrangements of the Asn54 and Leu145 mutants’ active
site, leading to less specific and less cytotoxic enzymes
(Masip et al., 2003; Siemer et al., 2004). Another important
observation was that ribotoxins lack a residue equivalent to
RNase T1 Glu46, involved in discriminating guanine from
adenine (Gohda et al., 1994). The lack of this residue could
explain why this ribotoxin is only purine-specific when
assayed against naked RNA, and not guanine-specific, as is
the case for RNase T1 (Endo et al., 1983, 1988).
Residue Tyr48 in a-sarcin is conserved not only within
the ribotoxin family, but also within the larger group of
fungal extracellular RNases (Fig. 3) (Martı´nez-Ruiz et al.,
1999a, b). Tyr38 of RNase T1 forms a short hydrogen bond
with one of the phosphate oxygens in the RNase T1/30–GMP
complex, an interaction that may be more favourable in the
transition state (Loverix & Steyaert, 2001). AY48Fmutant of
a-sarcin was shown to be inactive against polymeric RNA
substrates, revealing the essential role of the OH group in
the Tyr48 phenolic ring (A´lvarez-Garcı´a et al., 2006). This
mutant was, again, active against ApA, revealing that it
retained ribonucleolytic activity at this level. In summary,
the removed OH group only contributes slightly to the
catalytic efficiency against ApA, but is essential for the
characteristic ribotoxin activity (specific degradation of
rRNA gene and SRL-like substrates).
Thus, Tyr48, Arg121 and Leu145 appear to be determi-
nants of the ribotoxin activity of a-sarcin. Studies of the
crystal structures of complexes of the a-sarcin-like ribotoxin
restrictocin with inhibitors led to the proposal that these
ribotoxins may use base flipping to enable cleavage at the
correct site of the SRL substrates (Yang et al., 2001). All
studies so far suggest that these three residues would enable
the base flipping performed by His50/Glu96/His137 that
permits RNase cleavage at a unique phosphodiester bond
(Yang et al., 2001).
In addition, the N-terminal hairpin has been shown to
modulate the catalytic activity of ribotoxins, in studies with
different mutants of mitogillin, another ribotoxin with only
a single substitution relative to restrictocin (Kao & Davies,
1999; 2000), and a-sarcin (Garcı´a-Ortega et al., 2001). These
studies included deletion variants in which this hairpin had
been eliminated without affecting the overall three-dimen-
sional structure of the protein (Garcı´a-Ortega et al., 2002,
2005; Garcı´a-Mayoral et al., 2004). These mutants [a-sarcin
D (7–22) and Aspf1 D (7–22)] retained their nonspecific
ribonucleolytic activity as well as their ability to specifically
cleave SRL-like oligonucleotides, but were not able to
specifically inactivate rabbit ribosomes, and therefore were
much less cytotoxic (Garcı´a-Ortega et al., 2002, 2005).
In conclusion, it is important to note the differences
exhibited by HtA. As expected, because it is a ribotoxin, this
protein caused the specific cleavage not only of rabbit 28S
rRNA gene, but also of the SRL-like oligonucleotides used as
substrates (Herrero-Gala´n et al., 2007). However, when less
specific substrates were employed, HtA showed quite dis-
tinct behavior, as reflected by the fact that it is not active
against poly(A) but is active against poly(C) (Herrero-Gala´n
et al., 2007). This behavior must be linked to the structural
differences displayed by HtA, but the interpretation is not
obvious, as the behavior has also been observed with other
wild-type and mutant ribotoxins (Nayak et al., 2001). Most
probably, this behavior reflects as yet unknown elements of
the catalytic mechanism.
Interaction with the SRL and the
ribosome
Ribosomes are different in terms of their components
among the three phylogenetic domains, Archea, Bacteria,
and Eukarya, but several functional regions are always
conserved, probably because they are essential to preserve
the protein biosynthesis machinery (Mears et al., 2002;
Uchiumi et al., 2002). One of them is the SRL (Szewczak &
Moore, 1995; Glu¨ck & Wool, 1996). This region is of
particular interest, owing to its crucial role in elongation-
related events in both prokaryotic and eukaryotic ribo-
somes. It contains the longest known universally conserved
ribosomal sequence (A2654–A2665 in the E. coli 23S rRNA
gene, and A4318–A4329 in the rat 28S rRNA gene), and
shows a unique RNA shape, which is structurally preserved.
It is so conserved that when the crystalline structure of the
Halobacterium marismortui large ribosomal subunit was
elucidated, the sequence of the 23S rRNA gene was fitted
into the electron density map, nucleotide by nucleotide,
starting from its SRL sequence (Ban et al., 2000). This SRL is
a distorted hairpin, with an unusually stiff central part, and
a GAGA tetraloop, a G-bulged cross-strand A-stack, a
flexible region, and a terminal A-form duplex (Fig. 2). It is
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not associated with any deep electrostatic potential pockets
of the ribosomes, and is not a major binding motif.
However, together with the L11-binding region, the L7/L12
stalk, and the ribosomal proteins L6 and L14 (Figs 2 and 5c),
it constitutes an elongation factor-binding site that is
required for correct functioning of the ribosome (Endo &
Wool, 1982; Cameron et al., 2002; Van Dyke et al., 2002).
The L11-binding domain sequence is also universally con-
served, in good agreement with its essential role (Mears
et al., 2002). Interestingly, the spatial orientation in the
ribosome of both the SRL and the L11-binding domain
varies not only among the different phyla (Ramakrishnan &
Moore, 2001; Mears et al., 2002; Uchiumi et al., 2002), but
also during the different steps of peptide bond formation
(Gabashvili et al., 2000). These differences might explain
why different RIPs display different affinities when assayed
against different ribosomal substrates (Schindler & Davies,
1977; Endo & Wool, 1982; Wool et al., 1992; Uchiumi et al.,
2002). Mutations affecting the sequence contained in the
SRL result in defective binding of elongation factors and
aminoacyl-tRNA, as well as a decrease in translational
fidelity (Liu & Liebman, 1996). Some of these mutations
are lethal, reinforcing the importance of this region for the
translational machinery (Leonov et al., 2003). Studies on the
dynamics and kinetics of the ribosome show considerable
mobility of this region, known as the GTPase center, and its
possible involvement in conformational changes essential
for the correct performance of translation (Nilsson &
Nissen, 2005).
Extensive studies using small synthetic oligoribonucleo-
tides mimicking the SRL sequence (Correll et al., 1998, 1999,
2003; Correll & Swinger, 2003) have shed light on the rRNA
identity elements needed for ribotoxin recognition of the
phosphodiester bond to be cleaved. These SRL analogs are
indeed specifically recognized and cleaved by the ribotoxins
(Endo et al., 1988; Kao et al., 2001), although larger amounts
of enzyme need to be employed, as mentioned in the
previous section, indicating that the recognition is not as
specific as with the whole ribosome. Unquestionably, they
have been of great help, because they do maintain the
structural features of the SRL within the complete ribosome
and have been used to establish the structural determinants
needed for the recognition between the SRL and ribotoxins.
Thus, docking models and kinetic experiments were used to
predict rRNA and protein regions capable of establishing
interactions with the ribotoxins (Yang &Moffat 1996; Pe´rez-
Can˜adillas et al., 2000; Correll et al., 2004; Garcı´a-Mayoral
et al., 2005b). Some of these predictions were confirmed by
the determination of the crystal structures of restrictocin–
inhibitor complexes made with several SRL-like RNA oligo
variants (Fig. 5a) (Yang et al., 2001). These studies included
the resolution of the structures of twomutant versions of the
oligonucleotides that mimic the 28S rRNA gene SRL motif
(Correll et al., 2003), as well as of three other different SRL
analogs in complex with restrictocin (Yang et al., 2001).
According to these results, there are two SRL areas that are
recognized by both toxins and elongation factors, the GAGA
tetraloop and the bulged G2655 (Fig. 2) (Moazed et al.,
1988; Glu¨ck &Wool, 1996; Munishkin & Wool, 1997; Pe´rez-
Can˜adillas et al., 2000). Thus, G2655 represents the most
critical site for binding of elongation factors (Munishkin &
Wool, 1997). However, the primary determinant of recogni-
tion does not seem to be the nucleotide type, but rather the
SRL conformation (Munishkin & Wool, 1997; Correll et al.,
1999, 2003). Molecular dynamics simulation of two SRL
structures based on crystal structures of E. coli and rat SRL
motifs revealed that the GAGA tetraloop is the most
dynamic part of this motif (Sˇpacˇkova´ & Sˇponer, 2006). In
fact, GNRA tetraloops adopt an unfolded geometry upon
binding of elongation factors and/or toxins, as was observed
in the above-mentioned SRL–restrictocin complexes (Yang
et al., 2001). It has already been mentioned that these studies
led to the proposal that ribotoxins may use base flipping to
enable cleavage at the correct site of the SRL substrates (Yang
et al., 2001), and that this base flipping may be a common
cleavage mechanism for endonucleases acting on folded
substrates, as is the case for ribotoxins (Yang et al., 2001).
In summary, according to the above-mentioned results, two
distant regions of the ribotoxin molecules participate in
their specific interaction with the SRL. The Lys-rich region
corresponding to loop 3 of a-sarcin interacts with the
negatively charged phosphodiester bond around the bulged
G, and the sequence stretch of loop 2, comprising residues
51–55 (a sequence stretch that includes the mentioned
Asn54) and some residues from loop 5, contacts the
conserved GAGA tetraloop that contains the sequence
cleaved by the toxin (Fig. 5s).
It is, however, quite obvious that these interactions with
the SRL do not by themselves explain the exquisite specific
activity displayed by ribotoxins against intact ribosomes.
Consequently, some other interactions with additional ribo-
somal elements are required. In this regard, it has recently
been shown that the ribosomal context enhances the reac-
tion rate by several orders of magnitude. This catalytic
advantage seems to arise from favorable electrostatic inter-
actions with the ribosome (Korennykh et al., 2006). The
positively charged ribotoxins bind with high affinity and
speed, thereby enhancing the rate of SRL cleavage by several
orders of magnitude, matching the catalytic efficiency of the
fastest known enzymes (Korennykh et al., 2006). a-Sarcin’s
surface, for example, is highly charged: 39% of the surface is
composed of charged side chains and 26% of polar side
chains (Pe´rez-Can˜adillas et al., 2000). Therefore, these
results suggest a mechanism of target location whereby a-
sarcin encounters ribosomes randomly and diffuses within
the ribosomal electrostatic field to the SRL. Long ago, it was
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reported not only that the ribonucleolytic activity of a-
sarcin was completely inhibited by NH4
1, K1, or Na1 at
concentrations higher than 0.2M, as well as by millimolar
levels of some divalent cations such as Ca21, Mn21, or Mg21
(Endo et al., 1983; Martı´nez del Pozo et al., 1989), but also
that it binds Zn21, Cd21, and Co21, with an affinity
corresponding to dissociation constants in the millimolar
range (Martı´nez del Pozo et al., 1989). This binding was
proposed to be mediated by interactions with the active site
His side chains, and affected fluorescence emission, most
probably modifying the microenvironment of Trp51.
Whereas in these studies it was shown that Zn21 cations
were effective inhibitors of its ribonucleolytic activity, it was
also shown that the inhibition promoted by most of the
other cations studied was due to the establishment of
interactions with the substrates used, rather than to the
existence of a specific interaction with the protein (Martı´nez
del Pozo et al., 1989).
Within this context, it must be considered that internal
motions allow recognition elements to screen a significant
part of the conformational space, increasing the chances of
successful binding. As explained earlier, residues 1–26 in a-
sarcin form a long b-hairpin that can be considered as two
consecutive minor b-sheets connected by a hinge region.
The second b-sheet, coincident with residues 7–22, is one of
the regions with the highest conformational flexibility,
appearing to be folded independently from the protein core
(Pe´rez-Can˜adillas et al., 2000, 2002; Garcı´a-Mayoral et al.,
2004). The results obtained with the previously mentioned
D (7–22) a-sarcin mutant suggested that this protein would
interact with the ribosome in at least two regions, i.e. the
well-known SRL of the rRNA gene, and a different region
recognized by the b-hairpin of the protein (Garcı´a-Ortega
et al., 2002). Its three-dimensional structure in solution
(Garcı´a-Mayoral et al., 2004) showed that the folding of
wild-type a-sarcin was preserved, including the spatial
conformation of the loops. The most significant differences
were concentrated in loop 2, the new orientation of loop 3,
and the dynamics of loop 5, where conformational hetero-
geneity was observed as a consequence of the removal of
important interactions with residues in the native motif
(Garcı´a-Mayoral et al., 2004). Thus, its structural integrity
and ability to specifically cleave SRL-like oligos was pre-
served, but the a-sarcin-specific recognition of the ribosome
disappeared. Modeling the highly specific ribotoxin recogni-
tion of ribosomes using three-dimensional structures of
wild-type and D(7–22) a-sarcins suggested two more hither-
to unidentified interactions (Garcı´a-Mayoral et al., 2005b).
One of them would occur between a short sequence stretch
of the a-sarcin loop 2 and the ribosomal protein L6 (Fig.
5c). The second would occur between the residues corre-
sponding to the deleted distal part of the b-hairpin and
protein L14 (Fig. 5c). These two prokaryotic ribosomal
proteins are immediate neighbors of the SRL (Fig. 2a), are
present in the three living phyla (Ban et al., 2000), and seem
to undergo the most substantial changes, according to the
X-ray and cryo-electron microscopy maps of the ribosome
(Ban et al., 2000; Gabashvili et al., 2000). Obviously, the
interaction involving the b-hairpin would not be possible
for the deletion mutant, and appears to be crucial for the
specific ribosome recognition (Garcı´a-Mayoral et al.,
2005b). This hypothesis was reinforced by the observation
that a region homologous to the 11–16 sequence of a-sarcin
can be found in (EF-2) from S. cerevisiae (Kao & Davies,
1999; Garcı´a-Mayoral et al., 2005b). Both groups of poly-
peptides, ribotoxins and ribosomal proteins L14 (and their
L23 counterparts in eukaryotic organisms), represent fa-
milies of highly homologous proteins. The interacting
regions of a-sarcin and L14 are conserved but show some
degree of variability (Garcı´a-Mayoral et al., 2005b), espe-
cially regarding the L14 residues involved (L23 proteins have
sequences that are only distantly related). This fact helps to
explain not only the extraordinary catalytic efficiency of
ribotoxins against ribosomes, but also their different poten-
cies, depending on the origin of the ribosome assayed
(Schindler & Davies, 1977; Endo & Wool, 1982; Endo et al.,
1983; Garcı´a-Mayoral et al., 2005b).
Ribotoxins as natural killers of intact cells
It has already been explained how a-sarcin is able to
inactivate ribosomes in cell-free systems of a great variety of
organisms (Endo et al., 1993a, b; Kao & Davies, 1995), but it
displays marked selectivity when intact cells are used as
targets. This specificity seems to be determined by its ability
to penetrate cells. Thus, a-sarcin is active against transformed
or virus-infected mammalian cells, in the absence of any
other permeabilizing agent (Ferna´ndez-Puentes & Carrasco,
1980; Carrasco & Esteban 1982; Olmo et al., 1993, 2001;
Turnay et al., 1993; Stuart & Brown, 2006). The protein was
also cytotoxic, inhibiting protein biosynthesis, when assayed
against eight different human and rat tumor cell lines of
mesenchymal, glial or epithelial origin (Turnay et al., 1993):
This effect was saturable and consistent with passage across
the cell membrane being the rate-limiting step, but no
membrane damage or mitochondrial activity alterations were
detected (Turnay et al., 1993). Again, these experiments
confirmed that a-sarcin exhibits an intrinsic and rather
specific cytotoxic character, in the absence of any external
permeabilizing agent, virus included, when assayed against
some transformed cell lines. The particular reasons for this
selectivity at the molecular level have not been completely
established yet; however, as mentioned above, the presence of
acidic phospholipids on the outer leaflet of the membrane
seems to be one of the determining factors (Connor et al.,
1989; Gasset et al., 1989, 1990; Zachowski, 1993).
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The mechanism of internalization of a-sarcin into intact
human rhabdomyosarcoma cells and the cellular events
resulting in the induction of cell death have been studied
(Olmo et al., 2001). According to these results, the toxin is
internalized via endocytosis involving acidic endosomes and
the Golgi, as deduced from the ATP requirement and the
effects of NH4Cl, monensin and nigericin on its cytotoxicity.
In addition to the specific cleavage of 28S RNA associated
with protein biosynthesis inhibition, a-sarcin killed rhabdo-
myosarcoma cells via apoptosis. This apoptosis was not just
a general direct consequence of protein biosynthesis inhibi-
tion, as deduced from a comparative analysis of the effects of
a-sarcin and cycloheximide (Olmo et al., 2001). Further-
more, experiments with a catalytically inactive a-sarcin
mutant (H137Q), which is neither toxic nor apoptotic,
revealed that it was directly related to the catalytic effects of
the toxin on the ribosomes, as this mutant displays identical
lipid-interacting abilities to those of the wild-type protein
(Lacadena et al., 1995).
The loss of the positive charge at the position correspond-
ing to a-sarcin Arg121 produced a dramatic impairment of
its ability to interact with phospholipid membranes (Masip
et al., 2001), supporting the conclusion that Arg121 is a
crucial residue for the characteristic cytotoxicity of a-sarcin
and presumably of the other fungal ribotoxins. In agreement
with their altered ribonucleolytic and lipid-interaction ac-
tivities, all of the mutants studied with mutations affecting
the enzymatic specificity of the protein, especially the
deletion D(7–22) mutant, showed diminished cytotoxic
effects on human rhabdomyosarcoma cells (Garcı´a-Ortega
et al., 2002). Even restrictocin shows a lower phospholipid-
interacting ability, which is correlated with decreased cyto-
toxicity (Garcı´a-Ortega et al., 2001), as mentioned earlier in
this review. On the other hand, HtA shows a very similar
cytotoxic potency, in terms of IC50 (concentration required
to produce 50% of protein biosynthesis inhibition) (Her-
rero-Gala´n et al., 2007).
Ribotoxins as allergens
Fungi represent one of the principal sources of allergens.
Aspergillus fumigatus, a human pathogenic species, has been
well studied as an opportunistic pathogen (Walsh & Pizzo,
1988; Bodey & Vartivarian, 1989). Invasive infection is
usually fatal unless treated early, and even then, antifungal
therapy is often unsuccessful. The incidence of fungal
infections has risen lately, owing to the increase in the
number of immunocompromised patients, and A. fumigatus
infection is common postoperatively (Pasqualotto, 2006). A
link between fungal allergy and severe asthma is generally
accepted, but is still poorly understood (Ronning et al.,
2005; Denning et al., 2006). Among the reasons why A.
fumigatus can behave as a human pathogen is its ability to
grow quickly at temperatures as high as 50 1C, it being the
most thermophilic of the Aspergillus spp. (Ronning et al.,
2005); all the other known ribotoxin-producing fungi can
scarcely grow when cultured above 30 1C. It is also remark-
able that A. fumigatus is a more common source of allergy
and asthma than either A. nidulans or A. oryzae, the other
two Aspergillus spp. whose genome sequences have been
determined (Galagan et al., 2005; Machida et al., 2005;
Nierman et al., 2005). Interestingly, all A. fumigatus allergens
have close homologs in the other two species, with the
exception of the ribotoxin Aspf1 and the metalloprotease
Aspf5 (Ronning et al., 2005), but it is not yet clear whether
Aspf1 is a critical factor in triggering an allergic response. In
this regard, it should be remembered that allergens are
usually identified as those proteins recognized by the IgE
antibodies contained in the sera of allergic patients. In
relation to this, restrictocin was also found in the urine of
patients with disseminated aspergillosis (Arruda et al., 1990,
1992; Lamy et al., 1991), and antibodies have been also used
to prove that it accumulates in the vicinity of nodes of fungal
infection (Lamy et al., 1991). Although it has been proven
that Aspf1 is not a major virulence factor in A. fumigatus
infections (Paris et al., 1993; Smith et al., 1993, 1994), this
protein is clearly involved in the pathogenicity of allergic
bronchopulmonary aspergillosis (ABPA), the most severe
form of allergic inhalant diseases, as these patients show high
levels of Aspf1-specific IgE (Kurup et al., 1994; Garcı´a-Ortega
et al., 2005). ABPA has a prevalence of 1–2% in patients with
persistent asthma, but this value increases to 15% in cystic
fibrosis patients (Greenberger, 2002; Kurup et al., 2006). The
explanation for A. fumigatus being the mold usually involved
in these diseases seems to be, again, its ubiquity and its small
spores, which grow optimally at 37 1C. Thus, it can colonize
the respiratory tract of the host, leading to the onset of the
pathologic events (Banerjee & Kurup, 2003).
Extracts of A. fumigatus are frequently used to diagnose
allergic reactions, but they are highly complex mixtures,
containing up to 200 different proteins and glycoproteins
and low molecular weight compounds (Piechura et al.,
1983), and are very difficult to standardize. Attempts to
improve diagnosis are focusing on the employment of
homogeneous standard preparations of recombinantly pro-
duced allergens (Crameri et al., 1998; Kurup et al., 2006). In
this regard, it is therefore important to point out that Aspf1
was the first recombinant allergen tested in vivo (Moser
et al., 1992), and showed complete concordance with
serologic determinations (Moser et al., 1992; Crameri et al.,
1998; Hemmann et al., 1999). Unfortunately, the recombi-
nant native allergen is not devoid of cytotoxic activity, and
can trigger anaphylaxis.
As mentioned before, ribotoxins have much longer loops
than the other nontoxic fungal RNases, which are suppo-
sedly involved in their specificity, toxicity and antigenicity.
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Once again, it must be noted that the D(7–22) region, which
contains the ribotoxin-characteristic N-terminal b-hairpin,
shows the highest amino acid sequence variability among
ribotoxins (Fig. 2) (Martı´nez-Ruiz et al., 1991a, b, 2001),
and is highly flexible and exposed (Pe´rez-Can˜adillas et al.,
2000; Garcı´a-Mayoral et al., 2004). Indeed, Aspf1 differs
from a-sarcin in only 19 (87% sequence identity) residues,
but five of these 19 amino acid differences are located at this
N-terminal b-hairpin. As it is generally assumed that the
exposed and highly flexible regions are usually good candi-
dates to be B-cell epitopes in proteins, this b-hairpin could
certainly be a major determinant of the immunoreactivity of
these proteins. This was confirmed through the production
and characterization of Aspf1, a-sarcin, and their corre-
sponding D(7–22) variants (Garcı´a-Ortega et al., 2002,
2005). First, these data confirmed the significant prevalence
of Aspf1-specific IgE antibodies in sera from patients
sensitized to Aspergillus (Garcı´a-Ortega et al., 2005), as
reported before by other authors (Kao et al., 2001; Green-
berger, 2002; Kurup et al., 2006). This result was particularly
important in the ABPA patients studied, as anti-Aspf1 IgE
antibodies were detected in 100% of them. Second, and
although several earlier studies with synthetic peptides
overlapping the above-mentioned region produced contro-
versial results regarding its antigenic behavior (Kurup et al.,
1998, Madan et al., 2004), the three proteins studied, Aspf1D
(7–22), a-sarcin, and a-sarcin D (7–22), showed marked
decreases in their reactivity to Aspf1 IgE antibodies (Garcı´a-
Ortega et al., 2005), indicating that the deleted portion was
involved in at least one allergenic epitope. However,
although important, this cannot be the only allergenic
epitope within this molecule, as deduced from enzyme-
linked immunosorbent assay (ELISA) inhibition experi-
ments. The essential residues for epitopes in Aspf1 are
changed in wild-type a-sarcin, as inferred from the fact that
the response against the sera of the patients was even lower
for the latter than for the Aspf1D (7–22) mutant. Despite
this decreased IgE reactivity, the prevalence of the three
Aspf1 variants remained essentially unaffected, and they
retained most of the IgG epitopes (Garcı´a-Ortega et al.,
2005). Thus, these noncytotoxic deletion variants of ribo-
toxins are promising molecules for use in immunomodulat-
ing therapies for Aspergillus hypersensitivity and diagnosis.
However, in vivo assays are still required to assess this
possibility.
Immunotoxins
One of the goals of antitumor therapy is the preparation of
immunotoxins according to the idea described by Ehrlich in
1906, who introduced the concept of targeting cancer cells
with a ‘magic bullet’ consisting of a tissue-specific carrier
that would deliver toxic agents to neoplastic tissue (Ehrlich,
1956). In the past decade, an increased amount of clinically
oriented research involving immunotoxins has been pub-
lished (Reiter & Pastan, 1998; Kreitman et al., 1999; Brink-
mann, 2000; Li et al., 2004). Immunotoxins are therapeutic
agents with a high degree of specificity, composed of
targeting moieties, such as antibodies or physiologically
important ligands (such as growth factors or cytokines),
linked to toxins, chiefly toxic proteins from plants or
bacteria (Brinkmann & Pastan, 1994; Reiter & Pastan, 1998;
Kreitman, 2001).
Initially, immunotoxins were prepared by conjugating
toxins to monoclonal antibodies. The targeting moiety of
these first-generation immunotoxins was the whole anti-
body molecule (Kreitman, 2000). As the binding sites for
antigen are on the variable regions of antibodies, further
studies were performed to verify that Fab fragments,
obtained after IgG papain digestion, retained the ability to
interact with antigens (Ward et al., 1989; Wo¨rn &
Plu¨ckthun, 2001), leading to the so-called Fab or Fv
immunotoxins, which were easily internalized because of
their smaller size (Brinkmann, 2000). The development of
advanced technologies allowed the production of recombi-
nant immunotoxins, stabilized by a flexible peptide (scFv)
or by a disulfide bridge between the variable domains
(dsFv), that can be expressed in several model organisms,
are easily modified by genetic engineering, and are more
stable (Kreitman, 2003; Li et al., 2004).
Regarding the toxin moiety, the most representative toxins
employed have been ricin from plants and Pseudomonas
exotoxin A (PE) or diphtheria toxin (DT) from bacteria.
Ricin is composed of two subunits linked together by a
disulfide bond, chain A being responsible for the glycosidase
activity, leading to the inactivation of ribosomes (Olsnes &
Pihl, 1973a, b; Endo et al., 1987), and is the one usually used
to make immunotoxins (Ghetie et al., 1993; Engert et al.,
1997; Schnell et al., 1998). Ricin depurinates a single nucleo-
tide contiguous to the phosphodiester bond cleaved by
ribotoxins (Endo & Tsurugi, 1987; Endo et al., 1987), a
catalytic action that renders the ribosome inactive too.
Different immunotoxins have been obtained that contain the
whole blocked ricin or deglycosylated chain A (Pastan et al.,
1992; O’Toole et al., 1998). Regarding bacterial toxins, PE and
DTare single-chain proteins that inhibit protein synthesis by
ADP-ribosylating EF-2 (Carroll & Collier, 1987). Among PE-
and DT-based immunotoxins, the most commonly used
involve truncated versions of the toxins, produced by genetic
excision of their binding domain, resulting in PE38 or PE40
variants (Kondo et al., 1988; Kreitman et al., 1990, 1993;
Pastan, 2003), and DT388 or DT389 variants (Foss et al.,
1998; LeMaistre et al., 1998), respectively.
Ribotoxins have several advantages for use in the design
of immunotoxins, namely, their small size, high thermo-
stability, resistance to proteases, and highly efficient
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ribonucleolytic activity (Gasset et al., 1994; Kao et al., 2001;
Martı´nez-Ruiz et al., 2001). Poor immunogenicity and low
toxicity in mice have also been described in relation to
restrictocin (Rathore & Batra, 1996). Thus, different ribo-
toxins have been used as components of immunotoxins
(Orlandi et al., 1988; Conde et al., 1989; Hertler & Frankel,
1989; Wawrzynczak et al., 1991; Better et al., 1992; Rathore
& Batra, 1996; 1997a, b; Rathore et al., 1997). Initially,
ribotoxin-based immunotoxins were constructed by chemi-
cal conjugation, as described for, among others, mitogillin
(Better et al., 1992), restrictocin (Orlandi et al., 1988; Conde
et al., 1989; Rathore & Batra, 1996) and a-sarcin (Wawr-
zynczak et al., 1991). Second-generation immunotoxins
were later designed, mostly related to restrictocin single-
chain immunotoxins produced by fusing restrictocin cDNA
with that encoding the scFv region of the monoclonal
antibody directed to the human transferrin receptor (anti-
TFR) (Rathore & Batra, 1997a, b), joined by a linear flexible
peptide to promote the independent folding of the two
immunotoxin moieties. These constructions were further
engineered to enhance the intracellular processing and
delivery of restrictocin (Goyal & Batra, 2000).
A few immunotoxins containing a-sarcin have been
described (Wawrzynczak et al., 1991; Rathore et al., 1997),
with a-sarcin chemically coupled to anti-TFR or anti-Fib75.
The a-sarcin used in these constructions was obtained either
from A. giganteus cultures (Wawrzynczak et al., 1991) or
from heterologous expression in E. coli cultures (Goyal &
Batra, 2000). Promising results were obtained when cyto-
toxicity was measured, with IC50 values similar to those
obtained with plant or bacterial toxin-based immunotoxins
(Goyal & Batra, 2000). The a-sarcin immunotoxin showed
equal stability and specific activity on the target cells and
similar pharmacokinetics to those of analogous immuno-
toxins (Wawrzynczak et al., 1991). However, further studies
with a-sarcin-based immunotoxins, including clinical trials,
were not performed, probably because of the large size of the
immunotoxin, which could hinder correct internalization in
solid tumors, or because of the low structural stability of the
immunoconjugates. It must be noted that these a-sarcin
immunotoxins were not made as recombinant second-
generation immunotoxins, such as the single-chain immu-
notoxins (scFv-IMTX) described later for restrictocin
(Rathore & Batra, 1997a, b), which gave better results in
terms of stability and cytotoxicity assays in vivo. Moreover
scFv-IMTX can be easily modified by genetic engineering to
improve the cytotoxic activity or to diminish unspecific
toxicity in vivo or immunogenicity.
In relation to this, a single-chain immunotoxin has been
recently produced in the methylotrophic yeast P. pastoris,
composed of the variable domains of the B5 monoclonal
antibody, specific against LewisY carbohydrates, which are
very abundant in carcinomas, bound to a-sarcin through a
peptide containing a furin cleavage site (scFv-IMTXaS)
(Lacadena et al., 2005). Pichia pastoris has emerged as a
robust heterologous expression host, owing to the efficient
secretory expression of complex recombinant proteins with
correct intramolecular and intermolecular disulfide bonds
that do not require additional in vitro unfolding and
refolding strategies, unlike most immunotoxins that are
heterologously expressed in bacteria (Cregg et al., 1993;
Gurkan & Ellar, 2003, 2005). Indeed, P. pastoris possesses
tightly regulated promoters, such as that of the alcohol
oxidase 1 gene (AOX1), which is uniquely suited for the
controlled expression of foreign genes (Cregg et al., 1989).
Thus, several immunotoxins have been successfully pro-
duced extracellularly in P. pastoris (Woo et al., 2002, 2004,
2006; Lacadena et al., 2005; Liu et al., 2005).
The monoclonal antibody (mAb) B5 belongs to a family
of mAbs directed against a LewisY-related carbohydrate
antigen that is overexpressed on the surface of many
carcinomas, including breast and colon solid tumors (Pastan
& Fitzgerald, 1991). Different members of the family have
been used as the targeting moiety in many immunotoxins,
such as mAb B3 (Brinkmann et al., 1991, 1993; Pai et al.,
1991, 1996; Benhar & Pastan, 1995a; Bera & Pastan, 1998),
mAb B1 (Pastan & Fitzgerald, 1991; Benhar & Pastan, 1995b;
Kuan & Pastan, 1996), and mAb B5 (Benhar & Pastan,
1995a, b). Indeed, mAb BR96 and mAb 3S193 have also been
evaluated for targeted immunotherapy (Trail et al., 1993;
Rosok et al., 1998; Scott et al., 2000). At least three of these
immunotoxins or immunoconjugates have recently been
evaluated in phase I trials in patients with cancer, with
promising results (Pai et al., 1996; Brinkmann, 2000).
scFv-IMTXaS produced in P. pastoris displays the char-
acteristic ribonucleolytic activity of a-sarcin and specific
cytotoxicity against targeted cell lines containing the LewisY
antigen (Lacadena et al., 2005). Furthermore, studies
on the characterization of genetically engineered immuno-
toxins based on that mentioned above, with increased
stability and affinity, are being performed (Lacadena et al.,
2005).
Conclusions and future prospects
Ribotoxins are unique RNases in terms of specificity and
cytotoxicity. Their remarkable and exquisitely specific ribo-
nucleolytic action, as well as their innate ability to cross
membranes, have been subjects of study for many years, and
are now quite well understood in molecular terms, through
the combination of a wide variety of structural, spectro-
scopic, biochemical, and cellular techniques, together with
the production and characterization of a large number of
mutants (Lamy et al., 1992; Gasset et al., 1994; Wool, 1997;
Kao et al., 2001; Martı´nez-Ruiz et al., 2001). The determina-
tion of several high-resolution ribosomal structures and the
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use of different lipid model vesicles and transformed cell
lines, susceptible or not to the action of these toxins, have
been of great help in deciphering the details of the cytotoxic
mechanism of ribotoxins at the molecular level. The exis-
tence of very similar and well-known noncytotoxic fungal
extracellular RNases, such as RNase T1, has been also very
useful. Presumably, these RNases are noncytotoxic because
they lack the above-mentioned ability to cross a phospholi-
pid bilayer. Thus, they have been, and still are, excellent
reference models with which to approach the study of the
behavior of this family of proteins. Unfortunately, the
natural function of ribotoxins still remains unknown, and
it is definitively one of the most interesting questions that
needs to be answered. In this regard, studies on the regula-
tion of ribotoxin production within the context of their
natural environment are still required. In fact, much indirect
evidence suggests that these proteins are synthesized under a
variety of stress conditions (Olson et al., 1965b; Meyer &
Stahl, 2002, 2003; Meyer et al., 2002), but further direct
characterization of these mechanisms and their regulation is
still needed. In relation to this, the eventual functional
connection with the prokaryotic TA systems (Condon,
2006) must not be dismissed. Indeed, the discovery and
characterization of HtA, a singular ribotoxin from the
structural and functional points of view, has opened a new
door to the acquisition of additional clues about the origin
and functionality of fungal ribotoxins. Further characteriza-
tion of this protein and similar ones, which will eventually
be discovered, given the increasingly rapid discovery of new
ribotoxins, will greatly improve our understanding of ribo-
toxin action in the natural context, mostly involving the
filamentous fungi.
This lack of knowledge about their natural function does
not, however, preclude their employment as therapeutic
agents. Despite the fact that their use as antitumor agents
was abandoned early, due to high toxicity (Roga et al., 1971),
it is also true that the actual accumulation of data about
their mechanism of action allows the optimistic view that
these ribotoxins, or probably some modified variants of
them, might be used with therapeutic aims. In relation to
this, the production of hypoallergenic mutants and immu-
notoxins stand out as the most feasible alternatives in the
mid-term future.
Regarding the first approach, it must be remarked how
Lactococcus lactis, a primary constituent of many industrial
and artisanal starter cultures used for the manufacture of a
wide range of fermented dairy products, has been exploited
through applications as a cell factory for metabolite and
membrane protein production and as a delivery system for
therapeutic molecules in the gastrointestinal tract (Steidler
et al., 2000, Kunji et al., 2005). The status of L. lactis as a
‘generally regarded as safe’ (GRAS) organism confers this
system with the features required to try immunotherapeutic
protocols for Aspf1-related allergic diseases. In relation to
this, L. lactis strains capable of secreting the above-men-
tioned hypoallergenic variants of Aspf1 have been obtained
(Alegre-Cebollada et al., 2005; Garcı´a-Ortega et al., 2005),
and although their use as potential delivery systems has yet
to be tested, they constitute one of the research directions
that should be immediately explored.
Immunotoxins are another promising alternative for the
employment of ribotoxins as therapeutic agents against
tumorigenic processes. The production in large amounts of
optimized immunotoxin versions of a-sarcin (Lacadena
et al., 2005) and other microbial RNases is well under way,
and it is definitively one of the research paths to be followed
in the near future.
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